血友病治疗前沿及展望
发布时间：2018-08-24 21:10
【摘要】：正血友病的治疗开始于19世纪40年代,最初仅为鲜血的直接输注。20世纪50至60年代,新鲜冰冻血浆及冷沉淀相继应用于临床。随后随着技术进步,凝血因子Ⅷ(FⅧ)和凝血因子Ⅸ(FⅨ)浓缩制剂陆续出现,该制剂使血友病家庭治疗成为可能,极大改善了血友病患者的生活质量[1]。但不幸的是,20世纪70至80年代,由于血源性替代产品的应用,世界范围内数千例血友病患者感染了人类免疫缺陷病毒(HIV)和丙型肝炎病毒
[Abstract]:The treatment of positive hemophilia began in the 1840s and was initially a direct transfusion of blood. In the 1950s and 1960s, fresh frozen plasma and cryoprecipitation were used in clinical practice. Subsequently, with the development of technology, clotting factor 鈪，
本文编号：2202049
[Abstract]:The treatment of positive hemophilia began in the 1840s and was initially a direct transfusion of blood. In the 1950s and 1960s, fresh frozen plasma and cryoprecipitation were used in clinical practice. Subsequently, with the development of technology, clotting factor 鈪，
本文编号：2202049
本文链接：https://www.wllwen.com/yixuelunwen/eklw/2202049.html
最近更新
教材专著
